Through integration of computational prediction with rigorous experimental validation, we aimed to demonstrate that LCD restores bone homeostasis in MRL/lpr mice by modulating NF-κB signaling pathways to inhibit inflammatory factor secretion in the distal femoral tissues, ultimately providing mechanistic insights for the clinical application of LCD in SLE-associated bone complications. Here, NFKB1 is linked to systemic lupus erythematosus.